Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mukherjee, 1997, Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera, Planta Med., 63, 367, 10.1055/s-2006-957705
Recio, 1995, Investigations on the steroidal anti-inflammatory activity of Triterpenoids from Diospyros Leucomelas, Planta Med., 61, 9, 10.1055/s-2006-957988
De Clercq, 1995, Antiviral therapy for human immunodeficiency virus infections, Clin. Microbiol. Rev., 8, 200, 10.1128/CMR.8.2.200-239.1995
Fulda, 1999, Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells, Int. J. Cancer, 82, 435, 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1
Pisha, 1995, Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis, Nat. Med., 1, 1046, 10.1038/nm1095-1046
Wick, 1999, Betulin acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing, J. Pharmacol. Exp. Ther., 289, 1306
Fulda, 1997, Betulin acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors, Cancer Res., 57, 4956
Fulda, 1998, Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells, Cancer Res., 58, 4453
Fulda, 2000, Betulin acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors, Med. Pediatr. Oncol., 35, 616, 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N
Costantini, 2000, Mithocondrion as a novel target of anticancer chemotherapy, J. Natl. Cancer Inst., 92, 1042, 10.1093/jnci/92.13.1042
Syrovets, 2000, Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and II alpha, Mol. Pharmacol., 58, 71, 10.1124/mol.58.1.71
Selzer, 2000, Effects of betulinic acid alone and in combination with irradiation in human melanoma cells, J. Invest. Dermatol., 114, 935, 10.1046/j.1523-1747.2000.00972.x
Fan, 1994, P53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA-damaging agents, Cancer Res., 54, 5824
Supino, 1992, Biological and enzymatic features of human melanoma clones with different invasive potential, Melanoma Res., 2, 377, 10.1097/00008390-199212000-00012
Supino, 1993, A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin, Int. J. Cancer, 54, 309, 10.1002/ijc.2910540224
Supino, 1995, MTT assay, 137
Donghi, 1993, Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland, J. Clin. Invest., 91, 1753, 10.1172/JCI116385
Benard, 1985, Characterization of a human ovarian adenocarcinoma line, IGROV-1, in tissue culture and in nude mice, Cancer Res., 45, 4970
Schmidt, 1997, Betulinic acid induces apoptosis in human neuroblastoma cell lines, Eur. J. Cancer, 33, 2007, 10.1016/S0959-8049(97)00294-3
Pratesi, 1999, A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts, Br. J. Cancer, 80, 1912, 10.1038/sj.bjc.6690620
Perego, 1996, Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems, Cancer Res., 56, 556
Supino, 1996, Modulation and cell cycle distribution of mutant p53 protein in a human small-cell lung carcinoma cell line after exposure to cytotoxic agents, Cell Pharmacol., 3, 253